Eli Lilly Corp. buy The Goldman Sachs Group, Inc.
Start price
08.04.25
/
50%
€678.00
Target price
08.04.26
€810.30
Performance (%)
30.89%
Price
17.12.25
€887.40
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Eli Lilly Corp. has seen massive gains of 30.89%. This prediction currently runs until 08.04.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 4.486% | 4.486% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $888.00 price target on the stock, down previously from $892.00.
Ratings data for LLY provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€719.00
12.10.25
12.10.25
€756.64
12.10.26
12.10.26
23.42%
17.12.25
17.12.25
